BOC Sciences provides customized chiral synthesis and chiral building block development services for pharmaceutical research, fine chemicals, materials science, agrochemical research, and functional molecule development. Our services include chiral route design, asymmetric synthesis, chiral pool synthesis, chiral resolution, enzyme-catalyzed reactions, chiral intermediate preparation, stereoisomer separation, and stereochemical confirmation.
Chiral synthesis is challenging because a target molecule must have the right structure, configuration, selectivity, and reaction compatibility. Medicinal chemists, process scientists, materials researchers, and CRO project teams often face limited access to the desired enantiomer, low stereoselectivity, racemization, difficult stereoisomer separation, incomplete chiral analysis, or intermediates that do not work well in later reactions. BOC Sciences helps clients choose suitable stereochemical strategies, optimize key reactions and separation methods, and confirm structures with reliable analytical data. This supports SAR studies, lead optimization, intermediate development, reference compound preparation, and functional molecule screening while reducing repeated trial-and-error.
BOC Sciences supports chiral building block preparation from natural and bio-derived sources, including plant materials, microbial cultures, and fermentation systems. Through extraction, isolation, cultivation, purification, and downstream chemical modification, we help clients obtain stereodefined compounds such as amino acid derivatives, carbohydrate-based synthons, terpene-derived scaffolds, hydroxy acid derivatives, and other naturally configured chiral intermediates.
For chiral targets that are unavailable from standard catalogs or require special substitution patterns, BOC Sciences provides customized chemical synthesis services. We design practical routes based on the target structure, desired configuration, functional group compatibility, synthesis scale, and downstream reaction needs. Our team supports chiral amines, alcohols, acids, heterocycles, spirocycles, bicyclic scaffolds, and analog-ready intermediates for pharmaceutical, materials, and specialty chemical research.
When racemic synthesis is more direct or practical, BOC Sciences helps clients obtain the desired stereoisomer through chiral resolution. Depending on compound properties, we may evaluate diastereomeric salt formation, crystallization, derivatization, enzymatic resolution, chiral HPLC, or preparative chiral separation. This service supports single-enantiomer preparation, enantiomer pair generation, stereochemical comparison, and chiral reference material development for research applications.
BOC Sciences applies chiral induction strategies to build stereocenters through controlled asymmetric reactions. Our chemists use chiral catalysts, ligands, auxiliaries, organocatalysts, enzymatic transformations, or substrate-controlled chemistry to improve stereoselectivity in key steps. This approach supports stereoselective reduction, hydrogenation, addition, amination, epoxidation, cyclization, and C-C or C-heteroatom bond formation for complex chiral building block synthesis.
BOC Sciences helps research teams move from target structure to route design, stereoselective synthesis, enantiomer enrichment, analytical confirmation, and decision-ready material for downstream studies.
We combine retrosynthetic planning, route risk assessment, protecting-group strategy, and building block synthesis expertise to prepare fragments that are compatible with medicinal chemistry and process research. Our team also evaluates stereochemical stability, downstream reaction needs, and practical route feasibility before synthesis begins.
BOC Sciences applies chiral HPLC, LC-MS, NMR, optical rotation, derivatization, and comparison with known references to evaluate enantiomeric composition and structural identity. These data help clients confirm whether the desired stereoisomer has been successfully prepared.
Our chiral analysis and separation capabilities support racemate resolution, diastereomer separation, salt screening, chiral column selection, and enantiomer enrichment strategy development. We select separation approaches according to compound polarity, stability, functional groups, and the target stereoisomer required for further research.
We select chiral catalysts, chiral ligands, and chiral auxiliaries according to substrate electronics, steric environment, desired configuration, and reaction compatibility. This supports more controlled asymmetric transformations and improves route design for complex chiral building blocks.
Our chemists support diverse chiral scaffolds, from amino acid derivatives and chiral amines to complex heterocycles, spiro systems, carbohydrate-derived synthons, and ligand precursors. Key categories include:
| Category | Representative Structures |
| Chiral Amino Acids & Derivatives | D-/L-amino acids, N-methyl amino acids, unnatural amino acids, fluorinated amino acids, alkynyl amino acids, cyclopropyl amino acids, amino alcohols, and amino acid esters |
| Chiral Amines | Primary, secondary, and tertiary chiral amines; cyclic amines such as pyrrolidines, piperidines, piperazines, and azetidines; benzylamines and α-chiral amines |
| Chiral Alcohols & Diols | Chiral benzyl alcohols, allylic alcohols, 1,2-diols, 1,3-diols, chiral cyclohexanols, and protected hydroxy intermediates |
| Chiral Carboxylic Acids & Esters | α-Hydroxy acids, amino acid-derived carboxylic acids, chiral malonate esters, chiral cyclopropane carboxylic acids, and protected acid derivatives |
| Chiral Epoxides & Aziridines | Terminal epoxides, 2,3-epoxy alcohols, substituted epoxides, aziridines, and aziridine-2-carboxylic acid derivatives |
| Chiral Heterocyclic Building Blocks | Chiral pyrrolidines, piperidines, morpholines, oxazolines, thiazolines, indolines, lactams, and nitrogen-containing bicyclic motifs |
| Chiral Spiro & Bridged Systems | Chiral spiro diols, spiro phosphine ligand derivatives, norbornene derivatives, bicyclic amines, and bridged oxygen/nitrogen-containing scaffolds |
| Chiral Carbohydrate Derivatives | Chiral sugar aldehydes, sugar amines, deoxy sugars, amino sugars, glycosylation building blocks, and protected carbohydrate synthons |
| Chiral Phosphorus, Sulfur & Boron Compounds | Chiral phosphine ligand precursors, chiral sulfoxides, chiral sulfides, chiral boronate esters, and organoboron intermediates |
| Chiral Aryl & Heteroaryl Building Blocks | Axially chiral biaryls, BINOL derivatives, planar chiral ferrocene derivatives, chiral benzofurans, chiral indoles, and substituted heteroaryl scaffolds |
Share your target structure, desired configuration, expected downstream reaction, stereochemical concern, analytical preference, and quantity need. Our specialists will design a project-specific plan covering route feasibility, reaction types, stereochemical control, purification, and confirmation.
We first understand the client's target compound, synthesis goals, technical challenges, required scale, desired configuration, and downstream application needs to define the project direction.
Based on project communication, our synthesis experts use route design experience and route-planning platforms to propose multiple suitable synthetic strategies for comparison and selection.
After route selection, we carry out synthesis, optimize key reaction conditions, and monitor stereochemical integrity during critical steps. The target compound is purified by suitable methods such as chromatography, crystallization, salt formation, or chiral separation, then characterized by NMR, LC-MS, chiral HPLC, optical rotation, or other project-relevant analytical methods.
The final chiral building block is packaged according to compound properties and delivered with a technical summary, analytical results, stereochemical information, and handling notes when needed.
Clients often encounter racemization or epimerization when working with α-chiral carbonyl compounds, activated amines, amino acids, or heterocyclic intermediates. In related projects, BOC Sciences has helped identify high-risk reaction steps and adjust protecting groups, base strength, reaction temperature, activation chemistry, and workup conditions. We also add chiral HPLC checks at key stages to monitor stereochemical integrity during synthesis.
Some clients have found that commercial sources only provide one stereoisomer, or do not offer the exact substitution pattern needed for SAR studies. BOC Sciences evaluates whether the target is best accessed through asymmetric synthesis, chiral pool transformation, or chiral resolution. When needed, we can prepare both enantiomeric series and design analog-ready intermediates for lead optimization.
Clients commonly face purification challenges when enantiomers or diastereomers behave similarly in standard chromatography or crystallization systems. BOC Sciences supports these projects by screening chiral stationary phases, salt formation conditions, derivatization methods, solvent systems, and crystallization behavior. We also combine orthogonal analytical methods to track separation results and isolate the target stereoisomer for downstream use.
In previous projects, some clients obtained chiral fragments that were structurally correct but difficult to use in the next coupling, derivatization, or scaffold expansion step. BOC Sciences reviews the client's downstream chemistry before route design, then selects suitable protecting groups, leaving groups, coupling handles, and orthogonal reactivity so the final building block can support medicinal chemistry expansion, hit to lead chemistry, and structure-diversification plans.
Collaborate with BOC Sciences to access custom chiral fragments, enantiomer pairs, protected intermediates, scaffold libraries, and route-ready building blocks supported by thoughtful stereochemical design and analytical confirmation.
BOC Sciences is supported by experienced synthetic chemists, including PhD-level researchers with strong backgrounds in asymmetric synthesis, chiral resolution, heterocyclic chemistry, and complex intermediate development.
Each project follows a clear workflow from requirement analysis and route design to synthesis, purification, characterization, and final review, helping reduce route uncertainty and improve project reliability.
With flexible project management and responsive communication, we help clients move chiral building block projects forward efficiently, from early route evaluation to compound preparation and delivery.
Our integrated synthesis and analytical platform supports asymmetric synthesis, enzyme-catalyzed reactions, chiral separation, chromatography, NMR, LC-MS, chiral HPLC, and other technologies for reliable compound development.
Client Needs: A medicinal chemistry team needed a protected (S)-azetidine building block bearing a boronate handle for rapid Suzuki diversification. Commercial analogs lacked the required substitution pattern and gave poor compatibility in the client's planned coupling sequence.
Challenges: The azetidine ring was sensitive to strong base, and an early deprotection attempt caused partial racemization. The target also required orthogonal N-protection and a functional handle that survived purification.
Solution: We designed two asymmetric routes around a protected azetidine core, comparing chiral-pool starting material conversion with catalytic hydrogenation of an unsaturated precursor. Sixteen reaction screens evaluated base, solvent, temperature, and protecting-group order. Enantiomeric composition was monitored by chiral HPLC, while NMR and LC-MS confirmed structural identity, allowing selection of the cleaner, shorter route for analog library expansion.
Outcome: The selected route provided a stereochemically reliable building block with a coupling-ready handle, enabling the client to expand a focused analog series without redesigning the scaffold.
Client Needs: A process research group required an enantiomerically enriched β-amino alcohol intermediate for a substituted morpholine series. Their previous racemic route produced difficult-to-separate stereoisomers and inconsistent downstream conversion.
Challenges: The intermediate contained a base-sensitive stereocenter and a secondary amine that complicated salt formation. Standard achiral purification did not separate the enantiomers sufficiently for comparative route decisions.
Solution: We combined enzymatic kinetic resolution with salt-screening of the enriched amine intermediate. Twelve enzyme panels and eight resolving-acid conditions were evaluated on small-scale batches, followed by chiral HPLC, optical rotation comparison, and derivatization-based NMR review. The optimized sequence reduced racemization during deprotection and produced material suitable for parallel SAR synthesis.
Outcome: The client received a practical enrichment route and analytical method package that clarified the stereochemical source of downstream performance differences.
Client Needs: A specialty chemical team needed both enantiomers of a substituted bicyclic heterocycle to evaluate stereochemical effects on odor profile, volatility, and material compatibility in an early formulation concept.
Challenges: The bicyclic scaffold contained adjacent stereocenters and an oxidation-sensitive sulfur substituent. Initial route scouting suggested that late-stage functionalization could erode stereochemical integrity.
Solution: We prepared both enantiomeric series using asymmetric allylation followed by stereoretentive functional-group interconversion. More than 30 analog precursors were tracked by chiral HPLC, LC-MS, and 1D/2D NMR. For two sterically hindered heterocycles, we adjusted the coupling order and used a milder metal-catalyzed step to protect the stereocenter while improving downstream diversification.
Outcome: The project delivered both enantiomeric series with clear stereochemical documentation, helping the client select the preferred configuration for further specialty chemical evaluation.
Chiral building blocks help medicinal chemistry teams introduce defined three-dimensional structures into drug-like molecules from the earliest synthetic stage. Because many biological targets are chiral, different stereoisomers of the same scaffold may show different binding modes, potency, selectivity, solubility behavior, or metabolic profiles. Using a well-designed chiral intermediate can reduce late-stage route redesign and support clearer structure-activity relationship analysis. BOC Sciences supports custom chiral building block synthesis, stereochemical assignment, route evaluation, and analog preparation for small-molecule discovery programs.
Selection should be based on the target molecule’s stereochemical requirement, downstream coupling chemistry, functional group tolerance, protecting group strategy, and potential for analog expansion. In drug discovery, a useful chiral building block should not only fit one molecule but also enable rapid diversification, such as side-chain scanning, heterocycle replacement, or stereoisomer comparison. BOC Sciences can help evaluate commercially available and custom chiral fragments, including chiral amines, alcohols, acids, amino acid derivatives, fluorinated fragments, and constrained cyclic scaffolds, according to the client’s synthetic goals.
Chiral building blocks are widely used to construct chiral amines, amino alcohols, carboxylic acids, lactams, pyrrolidines, piperidines, morpholines, β-amino acids, fluorinated stereocenters, and substituted heterocycles. These motifs frequently appear in enzyme inhibitors, receptor modulators, protein-protein interaction modulators, nucleoside analogs, and targeted small-molecule research compounds. For medicinal chemistry teams, BOC Sciences can provide customized synthesis of single chiral fragments, stereoisomeric pairs, or focused chiral analog sets to support hit expansion, lead optimization, and scaffold refinement.
Stereochemical confirmation usually requires a combination of synthetic traceability and orthogonal analytical methods. Common approaches include chiral HPLC, chiral GC, optical rotation, NMR comparison, derivatization analysis, LC-MS molecular weight confirmation, and comparison with reference materials or downstream products when appropriate. For molecules with multiple stereocenters or possible diastereomeric mixtures, BOC Sciences designs structure-specific analytical strategies to distinguish the target configuration, related stereoisomers, and synthetic byproducts, helping research teams make confident decisions before using the building block in later-stage synthesis.
Custom synthesis is valuable when available building blocks do not match the required stereochemistry, protecting group pattern, functional handle, heterocycle type, ring constraint, fluorination pattern, or downstream coupling route. Drug discovery teams may need non-natural amino acids, chiral fluorinated fragments, constrained cyclic amines, chiral boronate derivatives, chiral alcohols, or fragments bearing special linker-ready positions. BOC Sciences supports feasibility assessment, asymmetric synthesis planning, intermediate preparation, stereochemical analysis, and series-based derivative synthesis, helping clients access chiral chemical space that better fits their candidate design strategy.
Our target contained a strained chiral heterocycle that repeatedly failed during deprotection. BOC Sciences redesigned the sequence, protected the stereocenter, and delivered analytical evidence that gave our chemistry team confidence.
— Dr. Wagner, Medicinal Chemistry Director
We had a racemic amino alcohol and needed the preferred enantiomer quickly for analog work. Their team evaluated several resolution options and explained the stereochemical data clearly in the final report.
— Bellini, Senior Process Chemist
The building blocks were not treated as isolated compounds. BOC Sciences considered our next coupling reactions, protecting groups, and analog plan, which made the materials much more useful for our SAR campaign.
— Wu, Drug Discovery Project Lead
We appreciated the combination of synthetic detail, chiral HPLC results, NMR interpretation, and practical route comments. The report helped our internal team decide which stereochemical route to pursue next.
— Bianchi, Principal Research Scientist
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
